baber/WOPTO huggingface dataset:
Patent MX-156870-A (MX)
Inventor: SMEYERS PIERRE A
IPC: A01G25/02
Filed: 1984-02-17
Abstract: A distributor or dripper includes a housing in which a closing member is movable from a seat adjacent an inlet to a seat adjacent an outlet. When in contact with the seat adjacent the outlet, the closing member forms with the housing a restricted flow channel. Prior to the point at which the closing member contacts the seat adjacent the outlet, a filter is formed which is maintained while the closing member continues movement toward the outlet.
Patent NZ-203684-A (NZ)
Title: Granular formulation for the stabilization of unstable drugs or food supplements
Inventor: YARWOOD R J
IPC: A23K20/195
Filed: 1983-03-24
Abstract: A granulation method involving polysaccharide gelling agents, e.g., alginic acid, and a metal (especially magnesium) salt, oxide or hydroxide, e.g., magnesium hydroxide, is developed for the stabilization of heat- and/or moisture-sensitive drugs or food supplements such as Efrotomycin, avermectins, milbemycins, mocimycin and other drugs. It has been found that the granules so obtained can be incorporated into various formulations without substantial decomposition.
Patent NZ-216698-A (NZ)
Title: Liquid mixing apparatus; blades of varying stiffness made from fibre reinforced plastics
Inventor: SALZMAN R N
IPC: B01F7/24
Filed: 1986-06-30
Abstract: Apparatus for mixing liquid and liquid suspension mediums in vessels with a mixing impeller shaft system of a composite of fibrous and plastic material of a structural configuration to enable the use of such material in commercial and industrial applications where the reaction loads of the medium on the system militate against the use of composite fibrous and plastic material. The system utilizes impellers having blades which distribute the reaction load through a hub on a mounting area of a shaft with keys and keyways in a manner to avoid stress risers unamicable to the composite material and which can cause failure thereof. Separate keys and keyways are provided to oppose the thrust due to the reaction loads and to oppose the torque due to such loads. Plural thrust keyways may be used to enable the impeller to be located at different positions on the shaft and at selected heights above the floor of the mixing vessel. Proplets on the tips of the blades extend entirely in the direction of the low pressure surface of the blades to control the flow field in the vessel and provide a more axial velocity profile of the inlet flow to the impeller which is nearly axial and substantially reduces the strength of the tip vortices.
Patent NZ-231190-A (NZ)
Title: Green coffee bean treatment: beans moisturised then heated in an inert gas atmosphere under positive pressure
Inventor: HUSAINI SAEED AHMAD
IPC: A23F5/02
Filed: 1989-10-27
Abstract: The moisture content of green coffee beans is increased to at least about 25% to 30% by weight based upon the weight of the moisturized beans. The moisturized beans then are heated in the presence of a substantially inert gas atmosphere under a positive pressure at a temperature sufficient and for a time sufficient for hydrolyzing and pyrolyzing the beans while substantially avoiding charring the beans. The treated beans then are dried.
Patent NZ-232034-A (NZ)
Title: Direct drive motor for aerial cableway: cable drum forms rotor
Inventor: NIGG ERNST
IPC: B61B12/02
Filed: 1990-01-08
Abstract: A cable railway installation comprising cable return disks (2) arranged at the bottom and top stations, at least one of which disks (2) is driven, and comprising a carrying and hauling cable (3) arranged around the cable return disks (2) and guided over guide or deflecting rolls (12) for moving transportation means, such as seats (5). The cable return disk (2) forms the rotor of the drive motor, especially a reluctance motor.
Patent NZ-238989-A (NZ)
Title: Activation of proteins chemically and production of fusion proteins biologically
Inventor: HEIM JUTTA
IPC: C07K16/00
Filed: 1991-07-16
Abstract: There is provided a novel method for the production of a biologically active protein comprising treating a fusion protein consisting of 1. one or multiple successive protein segment(s) each consisting of said biologically active protein the C-terminal amino acid of which is joined to a linker polypeptide sequence L and 2. a polypeptide tag joined to the C-terminal amino acid of said successive protein segment(s), or consisting of 1. a polypeptide tag joined to the N-terminal amino acid of 2. multiple successive protein segments each consisting of a linker polypeptide sequence L and said biologically active protein, with soluble yeast endoprotease yscF and with soluble yeast carboxypeptidase ysc alpha , and isolating said biologically active protein.
Patent NZ-261115-A (NZ)
Title: Cyclodextrin complexes comprising basic drug and an acid
Inventor: CHIESI PAOLO
IPC: A61K47/48
Filed: 1994-01-26
Abstract: PCT No. PCT/EP94/00205 Sec. 371 Date Nov. 15, 1995 Sec. 102(e) Date Nov. 15, 1995 PCT Filed Jan. 26, 1994 PCT Pub. No. WO94/16733 PCT Pub. Date Aug. 4, 1994A multicomponent inclusion complex of a basic drug, an acid and a cyclodextrin has enhanced water-solubility.
Patent NZ-284119-A (NZ)
Title: Communication of frequency, time or code division multiplexed high frequency signal over electrical power distribution network
Inventor: BROWN PAUL ANTHONY
IPC: H04B3/54
Filed: 1995-04-20
Abstract: Communications apparatus is disclosed which is adapted for use with a mains electricity transmission and/or distribution network, and includes signal transmission and/or reception means (232), and frequency conversion means (200-208) for converting the frequency of a signal transmitted or received by signal transmission and/or reception means to a frequency which facilitates improved propagation of the signal on the network. Preferably the signal transmission and/or reception means is adapted to operate according to a telephony standard which uses a relatively high carrier frequency (e.g. CT2), and the frequency conversion means is usable to convert a signal having a relatively high carrier frequency to a signal having a lower carrier frequency. <IMAGE>
Patent NZ-291262-A (NZ)
Title: E. coli heat-labile enterotoxin derivatives and their use as oral adjuvants
Inventor: CLEMENTS JOHN D
IPC: A61P31/04
Filed: 1995-07-18
Abstract: Methods and compositions are provided herein for the use of a novel mutant form of E. coli heat-labile enterotoxin which has lost its toxicity but has retained its immunologic activity. This enterotoxin is used in combination with an unrelated antigen to achieve an increased immune response to said antigen when administered as part of an oral vaccine preparation.
Patent NZ-296486-A (NZ)
Title: Manufacturing a multilayer semiconductor structure: nucleating surface located adjacent to at least one of the amorphous layers of semiconductor material
Inventor: GREEN MARTIN ANDREW
IPC: H01L31/076
Filed: 1995-12-01
Abstract: PCT No. PCT/AU95/00812 Sec. 371 Date May 29, 1997 Sec. 102(e) Date May 29, 1997 PCT Filed Dec. 1, 1995 PCT Pub. No. WO96/17388 PCT Pub. Date Jun. 6, 1996A semiconductor structure and method of forming the structure, where a supporting substrate or superstrate provides the mechanical strength to support overlying thin active regions. The thin dielectric layer deposited over the substrate or superstrate serves to isolate the deposited layers from the substrate from optical, metallurgical and/or chemical perspectives. A seeding layer is then deposited, the seeding layer being of n-type silicon with appropriate treatments to give the desired large grain size. This layer may be crystallized as it is deposited, or may be deposited in amorphous form and then crystallized with further processing. A stack of alternating polarity layers of amorphous silicon or silicon alloy incorporating n-type or p-type dopants in the alternating layers is then deposited over the seeding layer. Solid phase crystallization is then performed to give the desired grain size of 3  mu m or larger which can be achieved by extended heating of the layers at low temperature.
Patent NZ-302546-A (NZ)
Title: Use of raloxifene derivatives for decreasing serum calcium levels
Inventor: BOSS SUSAN M
IPC: A61P5/12
Filed: 1996-01-29
Abstract: Use of the benzothiophene raloxifene of the formula 1 in the preparation of a medicament for lowering serum calcium levels in a human. Raloxifene helps the treatment of hypercalcemia which results from too much calcium in the body and causes many conditions like cancer, sarcoidosis and more.
Patent NZ-307777-A (NZ)
Title: Defeating effects of color burst modifications to a video signal
Inventor: QUAN RONALD
IPC: H04N9/79
Filed: 1996-05-01
Abstract: n known colour burst modification processes for preventing recording of video signals, the colour burst present on each line of active video is modified, so that any subsequent video tape recording of the signal shows undesirable bands of colour error.  This process is defeated by first determining which video lines contain the colour burst modification, either prior experimentation or by on-line detection.  Then, some or all of the lines which include the modified colour bursts are modified to make the video signal recordable.  This may be done by shifting the phase of the modified colour bursts to its correct value, or by replacing the modified burst with one that is no longer effective, and mixing the modified colour burst signals with ones of the correct phase so as to eliminate most or all of the phase error.  Divisional filed as 337341
Patent NZ-330885-A (NZ)
Title: Process for preparation of vasoactive intestinal peptide analogs
Inventor: BOLIN DAVID ROBERT
IPC: C07K14/575
Filed: 1997-01-29
Abstract: This process is for the synthesis of vasoactive intestinal peptide analog Ac(VIP1-31)-NH2 from four  protected peptide fragments: Leu Lys  Lys  Gly  Gly  Thr Ala  Lys  Lys  Tyr  Leu  Asn  Asp Asn  Tyr Thr  Leu  Arg  Lys  Gln  Xaa  Ala His  Ser  Asp  Ala  Val  Phe  Thr Glu
Patent NZ-335971-A (NZ)
Title: Lining a duct with a layer of material comprising filaments of a thermoplastic material and filaments of reinforcing fibres
Inventor: BOYCE GERARD STEPHEN
IPC: B29C70/46
Filed: 1997-12-16
Abstract: A pipe (4) is rehabilitated by means of a tubular liner (5) which is introduced into the pipe in a contracted form, expanded into contact with the pipe wall, and hardened to retain its form. The liner (5) comprises composite material formed by knitting, braiding or weaving tows of intermingled filaments of thermoplastic and reinforcing fibre, the liner being heated during application to the pipe in order to melt the thermoplastic. The composite material may be created as a sleeve. Alternatively, a sheet of the material may be calendered and rolled up into a tubular form, overlapping edge margins of the sheet being bonded together after expansion of the tube into contact with the pipe wall.
Patent NZ-336724-A (NZ)
Title: Lipophilic derivative of a biologically active compound
Inventor: MYHREN FINN
IPC: A61K47/48
Filed: 1998-01-23
Abstract: A lipophilic derivative of a biologically active compound containing in its molecular structure at least one functional group selected from an alcohol, ether, phenyl, amino, amido, thiol, carboxylic acid and carboxylic acid ester group other than a nucleoside or nucleoside derivative is disclosed wherein this functional group of the biologically active compound has been replaced by a lipophilic group selected from: RCOO-, RCONH-, RCOS-, RCH2O-, RCH2NH-, COOCH2R , CONHCH2R and SCH2R with R is a lipophilic moiety selected from cis-8- heptadecenyl, trans-8-heptadecenyl, cis-10-nonadecenyl and trans-10-nonadecenyl provided that the biologically active compound is not i) dopamine; ii) a N-acylpeptide compound with one or two amino acids; iii) a steroid compound substituted by hydroxyl in position 3 on the steroid skeleton and having a saturated A-ring; iv) a compound of formula (I) wherein R1 and R2 are independently any substituent or v) a compound of formula (II) wherein R1'  and R2' are as defined in the specification or vi) a compound of formula (III) wherein R1", Y, Z, W and X are as defined in the specification. The biologically active compound can be an adrenocorticosteroid, nonsteroidal anti-inflammatory drug, anti-cancer drug, anti-microbial agent, anti-parasitic drug, cardiovascular drug, pesticide, fungicide or herbicide.
Patent NZ-504273-A (NZ)
Title: New composition of matter
Inventor: KARLSSON ANN-KRISTIN
IPC: A61K31/56
Filed: 1998-11-11
Abstract: A therapeutically acceptable glucocorticosteriod which is sterile according to the US Pharmacopoeia 23/NF18, wherein the glucocorticosteriod is selected from the group of glucocorticosteriods with an asymmetric acetal structure comprising 16á, 17á-butylidenedioxy, momethasone furoate, and beclamethasone dipropionate, and further esters, acetals and salts thereof.
Patent NZ-506903-A (NZ)
Title: Tablets quickly disintegrating in the oral cavity and process for producing the same
Inventor: MIZUMOTO TAKAO
IPC: H04L29/08
Filed: 1998-10-13
Abstract: Tablets quickly dissolving in the buccal cavity containing drugs, sugars and amorphous sugars and that are produced by molding and then drying under moistening. In the production process of these tablets, the amorphous sugars are irreversibly converted into crystalline sugars after the step of drying under moistening.  These tablets are therefore stable to moisture during storage and can maintain constant tablet stability.  In these tablets the above-mentioned sugars and amorphous sugars can be produced from sugars of a single type, which enables preparation design with a consideration of the stability of drugs.  Furthermore, these tablets make it possible to provide a production process with the use of conventional granulators and tabletting machines.
Patent NZ-507967-A (NZ)
Title: Substituted indolinones having an inhibiting effect on kinases and cycline/CDK complexes
Inventor: WALTER RAINER
IPC: C07D413/12
Filed: 1999-04-10
Abstract: Substituted indolines and isomers and salts thereof, of general formula (I) wherein; X is O or S; R1 is H, alkoxycarbonyl or alkanoyl; R2 is carboxy, alkoxycarboxy or an optionally substituted aminocarbonyl; R3 is an optionally substituted phenyl or naphthyl; R4 is H or alkyl; R5 is H, optionally substituted alkyl, indanyl, heteroaryl, pyrrolidinyl, piperidinyl, phenyl, pyridyl, pyrimidyl, or thienyl. Also described is a pharmaceutical composition of formula (I).
Patent NZ-512036-A (NZ)
Title: A system for guaranteeing a cheque using a card and authorisation code
Inventor: PHARMACIS GEORGE C
IPC: G06Q20/00
Filed: 1999-10-29
Abstract: A system for verifying and depositing a cheque comprises a cheque and a card having data relating to the owner of the card and an authorisation code. The card data is transmitted over a communication network to a control station. The control station checks the card authorisation against stored data, accesses guarantee means for an amount limit, and transmits approval with a cheque receipt identifier so that the account data base may have its balance adjusted.
Patent NZ-512348-A (NZ)
Title: Oral creatine supplementation for treating or preventing muscle disuse syndrome
Inventor: HESPEL PETER JOZEF LEO
IPC: A61K31/198
Filed: 1999-11-19
Abstract: The use of a creatine compound, in particular creatine or a creatine analogue, for the manufacture of a therapeutic preparation for the prevention or treatment of muscle disuse syndrome in a subject. The therapeutic preparation, more specifically, is for treating or preventing muscle disuse syndrome, comprising a suitable carrier, diluent or excipient and an effective amount of one or more creatine compounds. The muscle disuse syndrome may be a result of immobilization, or reduced level of activity due to disease, aging, or (mental or physical) handicap.
Patent NZ-515131-A (NZ)
Title: Crate, set of blanks, method for opening and machine to produce the crate, box or case, also provides easy dismantle of the crate
Inventor: BACQUES JEAN-YVES
IPC: B65D5/12
Filed: 2000-04-19
Abstract: The crate (1) comprises a first transversal side wall (4), which can be manually torn by a user from the rest of the crate. The other side walls (15) of the tray are exclusively fixed to the other side walls of the lid (3) by one or several partially pre-cut portions (16, 17) and/or several gluing points enabling the walls to be dismantled by manually moving them apart and exerting a force in a perpendicular position to said walls.  It also provides a machine for the production of the crate.
Patent NZ-519005-A (NZ)
Title: A technique for estimating the pose of surface shapes using tripod operators
Inventor: PIPITONE FRANK
IPC: G06T7/00
Filed: 2000-11-06
Abstract: A new technique known as "non-pose-distinctive placement removal" is combined with tripod operators (TOs), a method for interpreting range images, and is comprised of two steps. The first is training the system on a new object so that it will later be able to estimate the pose of that object when seen again in some range image. The second is the actual pose estimation, where a TO is placed at a random location on a new range image containing the object of interest. Then the nearest neighbor in feature space, the nearpoint, is computed. If the distance to the nearpoint is less than some appropriate threshold, then the surface is recognized and pose estimation proceeds by computing the six pose parameters of a central triangle of the new placement in the coordinate system of the range imaging instrument.
Patent NZ-521164-A (NZ)
Title: DNA encoding human acid-sensing ion channel BNaC4 (ASIC4)
Inventor: DUBIN ADRIENNE E
IPC: A61P25/28
Filed: 2001-02-13
Abstract: An isolated and purified nucleic acid molecule has the nucleotide sequence set forth in SEQ ID NO: 6 or 7 or the sequence complementary thereof. Expression vectors, recombinant host cells and methods for a human BnaC4 protein comprising the amino acid sequence set forth in SEQ ID NO:9 are described.
Patent NZ-525500-A (NZ)
Title: Audio visual means inside the vehicle to indicate the brake state of the trailer, being activated by the trailer brake hydraulic pressure
Inventor: WALKLEY IAN FRANCIS
IPC: B60Q1/44
Filed: 2003-04-28
Abstract: A set of indication means for a trailer-towing vehicle, connected to the stoplight wire of the trailer-towing vehicle, and controlled by switches that are activated by the hydraulic brake fluid pressure of a trailer being towed (61) Addition to 518330
Patent NZ-527275-A (NZ)
Title: Robust highly reflective optical construction
Inventor: SACCOMANNO ROBERT J
IPC: G02B6/036
Filed: 2002-01-29
Abstract: An optical construction (20) comprises an optically transmissive substrate (12), an optional adhesion-promoting layer (18) comprising an oxide form of at least one metal or metalloid deposited onto the surface of the optically transmissive substrate (12), a reflective layer (14) composed of a highly reflective metal overlaying the adhesion-promoting layer (18), and a protective layer (16) composed of a parylene polymer film bonded to the reflective metal layer (14).
Patent NZ-531751-A (NZ)
Title: Indexable containers
Inventor: BLOMFIELD GREGORY THOMAS
Filed: 2001-10-19
Abstract: A container erected with use of adhesive from a one piece blank of corrugated paperboard, the paperboard being of a kind having a fluted core lined by a liner sheet on each side, the container having at least a rectangular or square base with four peripheral walls and a column in each corner, each of two opposed walls being of double thickness of the corrugated paperboard and each of such walls having one or more upwardly extending indexing feature(s) indexable to the bottom of a like container for stack indexing, each indexing feature being immediately flanked on each flank in the wall by a hinge yet upwardly directed cross cut flutes of each thickness of the double thickness of the corrugated board in the wall are in the wall further away from the indexing feature each hinge immediately flanks, such cross cut flutes being at least at the level of, and not below, the upper most liner sheet of the corrugated paperboard in the hinge.
Patent NZ-534836-A (NZ)
Title: Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
Inventor: ENGEL JURGEN
IPC: A61K38/09
Filed: 2000-09-20
Abstract: Disclosed is a use of an Luteinizing Hormone Releasing Hormone (LH-RH) antagonist as an active agent for the preparation of a medicament for the therapeutic management of extrauterine proliferation of endometrial tissue, or for the therapeutic management of chronic pelvic pain and/or fallopian tube obstruction (FTO) associated with the extrauterine proliferation of endometrial tissue, wherein the medicament is in a form providing an amount of LHRH antagonist for a treatment of about 4 to 12 weeks in the form of weekly doses of about 3 to 10 mg per week, daily doses of about 0.25 mg to 0.5 mg/day or monthly doses of about 12 to 40 mg per month. These LH-RH antagonist as an active agent are also suitable for use in combination with at least one active agent selected from the group consisting of a contraceptive, a non-steroidal anti-rheumatic agent, an analgetic, an androgen other than the 17-alpha alkyl substituted testosterone or any combinations thereof for the therapeutic management of extrauterine proliferation of endometrial tissue, or for the therapeutic management of chronic pelvic pain and/or fallopian tube obstruction (FTO) associated with the extrauterine proliferation of endometrial tissue.
Patent NZ-535822-A (NZ)
Title: A building means
Inventor: MUIR ROBERT ANTHONY
IPC: E04B1/70
Filed: 2004-10-08
Abstract: A building means having a main plate portion (1), a ledge (2) extending outwards of a first face of the plate portion, a first bolt portion (4) extending outwards of the first face of the plate portion and a second bolt portion (5) extending outwards of a second face of the plate portion opposite the first face. The building means being formed such that when it is in use a structural member can be fastened to the first bolt portion while the plate portion is arranged at least partially behind exterior cladding of a building so that the ledge extends to beyond the cladding and rainwater contacting the first face of the plate portion can run down the first face and be guided by the ledge to a drain away position in front of the cladding.
Patent NZ-536896-A (NZ)
Title: Ink ribbon cartridge
Inventor: YAMAMOTO HIDEKI
IPC: B41J17/32
Filed: 2004-11-30
Abstract: An ink ribbon cartridge including a frame, supply shaft connecting members and take-up shaft connecting members is provided. The frame includes a first bearing member and a second bearing member, the supply shaft connecting members rotatably connect a supply shaft to the first bearing member and the second bearing member; and the take-up shaft connecting members for rotatably connect a take-up shaft to the first bearing member and the second bearing member. The supply shaft connecting members rotate about a first axis and the take-up shaft connecting members rotate about a second axis, and a predetermined distance is provided between the first axis and the second axis in order to provide a suitable amount of exposed ink ribbon while reducing a size of an image forming device in which the ink ribbon cartridge is to be accommodated.